[1] 贺海蓉, 李莉, 冯敖梓, 等. 1990~2017年全球膀胱癌发病率和死亡率的研究[J]. 中国循证医学杂志, 2020, 20(11): 1257.
[2] 刘怡辰, 向卉楠, 诸君, 等. 肿瘤相关巨噬细胞在肿瘤中作用的研究进展[J]. 肿瘤研究与临床, 2021, 33(2): 149. doi: 10.3760/cma.j.cn115355-20191230-00598
[3] GIL Z, BILLAN S. Crosstalk between macrophages and endothelial cells in the tumor microenvironment[J]. Mol Ther, 2021, 29(3): 895. doi: 10.1016/j.ymthe.2021.02.002
[4] 郑乃盛, 汪婷婷, 袁向亮, 等. 肿瘤相关巨噬细胞来源外泌体激活IFN通路促进胃癌细胞免疫逃逸[J]. 现代免疫学, 2021, 41(1): 24.
[5] DREYER F, BAUR A. Biogenesis and functions of exosomes and extracellular vesicles[J]. Methods Mol Biol, 2016, 1448: 201.
[6] FABRIS L, CADAMURO M, FOUASSIER L. Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor niche[J]. J Hepatol, 2021, 74(4): 771. doi: 10.1016/j.jhep.2020.12.019
[7] MAECKER H, VARFOLOMEEV E, KISCHKEL F, et al. TWEAK attenuates the transition from innate to adaptive immunity[J]. Cell, 2005, 123(5): 931. doi: 10.1016/j.cell.2005.09.022
[8] YUAN T, YANG Z, XIAN S, et al. Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury[J]. Exp Ther Med, 2020, 20(2): 917. doi: 10.3892/etm.2020.8775
[9] BADIA-VILLANUEVA M, DEFAUS S, FOJ R, et al. Evaluation of computationally designed peptides against TWEAK, a cytokine of the tumour necrosis factor ligand family[J]. Int J Mol Sci, 2021, 22(3): 1066. doi: 10.3390/ijms22031066
[10] SHI ZZ, WANG WJ, CHEN YX, et al. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma[J]. Cell Death Dis, 2020, 11(7): 597. doi: 10.1038/s41419-020-02801-6
[11] YING X, WU Q, WU X, et al. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages[J]. Oncotarget, 2016, 7(28): 43076. doi: 10.18632/oncotarget.9246
[12] HANAYAMA R. Emerging roles of extracellular vesicles in physiology and disease[J]. J Biochem, 2021, 169(2): 135. doi: 10.1093/jb/mvaa138
[13] SHINCY JS, PANAGAL M, JEREENA J, et al. Computational identification of microRNA-17-3p in breast cancer cells[J]. Microrna, 2017, 6(3): 208.
[14] XU Z, ZHANG Y, DING J, et al. miR-17-3p Downregulates mitochondrial antioxidant enzymes and enhances the radiosensitivity of prostate cancer cells[J]. Mol Ther Nucleic Acids, 2018, 13: 64. doi: 10.1016/j.omtn.2018.08.009
[15] XIANG P, YEUNG YT, WANG J, et al. miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition[J]. Int J Cancer, 2021, 148(12): 3071. doi: 10.1002/ijc.33528
[16] ZOU Y, DU Y, CHENG C, et al. FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway[J]. Exp Cell Res, 2021, 398(1): 112401. doi: 10.1016/j.yexcr.2020.112401
[17] ROSE M, MAURER A, WIRTZ J, et al. EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer[J]. Oncogene, 2020, 39(44): 6856. doi: 10.1038/s41388-020-01465-y
[18] GUO T, ZHAO L, ZHANG Y, et al. A monoclonal antibody targeting the dimer interface of epidermal growth factor receptor(EGFR)[J]. Immunol Lett, 2016, 180: 39. doi: 10.1016/j.imlet.2016.10.011